Role of intranasal fentanyl in breakthrough pain management in cancer patients

References

• PortenoyRKHagenNABreakthrough pain: Definition, prevalence and characteristicsPain1990412732811697056
   PubMed Web of Science ®Google Scholar
• HilgierMBole przebijajace w chorobie nowotworowejWspolcz Onkol20015168174
   Google Scholar
• ZeppetellaGO’DohertyCACollinsSPrevalence and characteristics of breakthrough pain in cancer patients admitted to a hospiceJ Pain Symptom Manage200020879210989246
   PubMed Web of Science ®Google Scholar
• Gómez-BatisteXMadridFMorenoFBreakthrough cancer pain: Prevalence and characteristics in patients in Catalonia, SpainJ Pain Symptom Manage2000204552
   Web of Science ®Google Scholar
• PortenoyRKPayneDJacobsenPBreakthrough pain: Characteristics and impact in patients with cancer painPain19998112913410353500
   PubMed Web of Science ®Google Scholar
• CaraceniAMartiniCZeccaEPortenoyRKWorking Group of an IASP Task Force on Cancer PainBreakthrough pain characteristics and syndromes in patients with cancer pain. An international surveyPalliat Med20041817718315198130
   PubMed Web of Science ®Google Scholar
• MercadanteSCharacteristics and mechanisms of BTCPEur J Palliat Care201017812
   Google Scholar
• DaviesANAssessment of BTCPEur J Palliat Care2010171315
   Google Scholar
• FoleyKMAcute and chronic cancer pain syndromesDoyleDHanksGChernyNCalmanKOxford Textbook of Palliative MedicineOxfordOxford University Press2004
   Google Scholar
• LeppertWKliniczna ocena bolu w chorobie nowotworowejTwoj Mag Med200553440
   Google Scholar
• MercadanteSRadbruchLCaraceniASteering Committee of the European Association for Palliative Care (EAPC) Research NetworkEpisodic (Breakthrough) Pain. Consensus Conference of an Expert Working Group of the European Association for Palliative CareCancer20029483283911857319
   PubMed Web of Science ®Google Scholar
• DaviesANDickmanAReidCStevensAMZeppetellaGThe management of cancer-related breakthrough pain: Recommendations of a Task Group of the Science Committee of the Association for Palliative Medicine of Great Britain and IrelandEur J Pain20091333133818707904
   PubMed Web of Science ®Google Scholar
• HanksGWde ConnoFChernyNExpert Working Group of the Research Network of the European Association for Palliative CareMorphine and alternative opioids in cancer pain: The EAPC recommendationsBr J Cancer20018458759311237376
   PubMed Web of Science ®Google Scholar
• HuiDBrueraEBreakthrough pain in cancer patients: The need for evidenceEur J Palliat Care2010175867
   Google Scholar
• ZeppetellaGOpioids for cancer breakthrough pain: A pilot study reporting patient assessment of time to meaningful pain reliefJ Pain Symptom Manage20083556356718258412
   PubMed Web of Science ®Google Scholar
• MercadanteSVillariPFerreraPBianchiMCasuccioASafety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio of with the oral daily morphine doseJ Pain Symptom Manage20042735235915050663
   PubMed Web of Science ®Google Scholar
• EntingRMucchianoCOldenmengerWHThe “pain pen” for breakthrough cancer pain: A promising treatmentJ Pain Symptom Manage20052921321715733812
   PubMed Web of Science ®Google Scholar
• de ConnoRipamontiCSaitaLRole of rectal route in treating cancer pain: A randomized crossover trial of oral versus rectal morphine administration in opioid-naive cancer patients with painJ Clin Oncol199513100410087707099
   PubMed Web of Science ®Google Scholar
• HassenbuschSJPortenoyRKCousinsMPolyanalgesic consensus conference 2003: An update on the management of pain by intraspinal drug delivery – report of an expert panelJ Pain Symptom Manage20042754056315165652
   PubMed Web of Science ®Google Scholar
• DaviesANVriensJKennettAMcTaggartMAn observational study of oncology patients’ utilisation of breakthrough pain medicationJ Pain Symptom Manage20083540641118222631
   PubMed Web of Science ®Google Scholar
• PortenoyRKAdjuvant analgesic agentsHematol Oncol Clin North Am1996101031198821562
   PubMed Web of Science ®Google Scholar
• FulfaroFCasuccioATicozziCRipamontiCPamidronate in incident pain due to bone metastasesJ Pain Symptom Manage20012263063111503631
   PubMed Web of Science ®Google Scholar
• LeppertWThe role of ketamine in the management of neuropathic cancer pain – a Polish experienceWellsCDProceedings of the Third International Congress on Neuropathic PainAthensMedimond International2010
   Google Scholar
• MercadanteSArcuriEFerreraPVillariPMangioneSAlternative treatments of breakthrough pain in patients receiving spinal analgesics for painJ Pain Symptom Manage20053048549116310622
   PubMed Web of Science ®Google Scholar
• LeppertWNowakowskaERola radioterapii w leczeniu objawow zaawansowanej choroby nowotworowejMed Paliat Prakt200823347
   Google Scholar
• BurtonAWReddySKShahHNTremont-LukatsIMendelEPercutaneous vertebroplasty – a technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case seriesJ Pain Symptom Manage200530879516043012
   PubMed Web of Science ®Google Scholar
• MoserKMTransdermal fentanyl in cancer painAm Fam Phys19924522892294
   Web of Science ®Google Scholar
• PrommerEThe role of fentanyl in cancer-related painJ Palliat Med20091294795419807240
   PubMed Web of Science ®Google Scholar
• AhmedzaiSBrooksDTransdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJ Pain Symptom Manage1997132542619185430
   PubMed Web of Science ®Google Scholar
• LeppertWLuczakJGorzelinskaLKozikowskaJWozniakSPThe use of transdermal fentanyl (Durogesic) in the treatment of cancer painJ Pain Symptom Manage200020S79
   Google Scholar
• GumulkaWSNarkotyczne leki przeciwboloweGumulkaWMeszarosJWspolczesne Metody Zwalczania BoluWarszawaOsrodek Informacji Naukowej Polfa2000
   Google Scholar
• ZyliczZvan Rijn-van der PlaatLLFentanyl may increase breathlessness in a patient with motor neuron diseaseJ Pain Symptom Manage20063219920016939840
   PubMed Web of Science ®Google Scholar
• ThomasJRvon GuntenCFManagement of dyspnoeaJ Support Oncol20031233415352640
   PubMedGoogle Scholar
• GaunaAAKangSKTrianoMLSwatkoERVanstonVJOral transmucosal fentanyl citrate for dyspnea in terminally ill patients: An observational studyJ Palliat Med20081164364818454622
   PubMed Web of Science ®Google Scholar
• SitteTNasal application of fentanyl citrate as symptom control against breathlessness in palliative care – overview and case reportWien Med Wochenschr2009159566570 German.20151344
   PubMedGoogle Scholar
• ZechDFJLehmannKAGrondSTransdermal/TTS/fentanyl in cancer pain managementProgr Palliat Care199423742
   Google Scholar
• LabrooRBPaineMFThummelKEKharaschEDFentanyl metabolism by human hepatic and intestinal cytochrome P4503A4: Implications for interindividual variability in disposition, efficacy, and drug interactionsDrug Metab Dispos199725107210809311623
   PubMed Web of Science ®Google Scholar
• MurtaghFEChaiMODonohoePEdmondsPMHigginsonIJThe use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practiceJ Pain Palliat Care Pharmacother20072151617844723
   PubMedGoogle Scholar
• DaleOHjortkjaerRKharaschEDNasal administration of opioids for pain management in adultsActa Anaesthesiol Scand20024675977012139528
   PubMed Web of Science ®Google Scholar
• AnonymousBol przebijajacy w chorobie nowotworowej Niedoceniany problem Nowa metoda leczenia Instanyl – fentanyl aerozol donosowyWarszawaNycomed Pharma2009
   Google Scholar
• FosterDUptonRChristrupLPharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgeryAnn Pharmacother2008421380138718728103
   PubMed Web of Science ®Google Scholar
• AnonymousInstanyl intranasal fentanyl spray. NYCOMED Available at: www.instanyl.com. Accessed 2010 Jul 9.
   Google Scholar
• StriebelHWKramerJLuhmannIRohierse-HohlerIRiegerAPharmakokinetische studie zur intranasalen gabe von fentanylDer Schmerz1993712212518415433
   PubMedGoogle Scholar
• KaasaSMoksnesKNolteTLefebvre-KuntzDPopperLKressHGPharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough painJ Opioid Manage201061726
   PubMedGoogle Scholar
• VissersDStamWNolteTLenreMJansenJEfficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancerCurr Med Res Opin2010261037104520199140
   PubMed Web of Science ®Google Scholar
• StriebelHWKoenigsDKrämerJPostoperative pain management by intranasal demand-adapted fentanyl titrationAnesthesiology1992772812851642347
   PubMed Web of Science ®Google Scholar
• ToussaintSMaidlJSchwagmaierRStriebelHWPatient-controlled intranasal analgesia: Effective alternative to intravenous PCA for postoperative pain reliefCan J Anesth20004729930210764171
   PubMed Web of Science ®Google Scholar
• GalinkinJLFaziLMCuyRMUse of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesiaAnesthesiology2000931378138311149429
   PubMed Web of Science ®Google Scholar
• ManjushreeRLahiriAGhoshBRLahaAHandaKIntranasal fentanyl provides adequate postoperative analgesia in pediatric patientsCan J Anesth20024919019311823399
   PubMed Web of Science ®Google Scholar
• ZeppetellaGNebulized and intranasal fentanyl in the management of cancer-related breakthrough painPalliat Med200014575810717724
   PubMed Web of Science ®Google Scholar
• ZeppetellaGAn assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: A pilot studyJ Pain Symptom Manage20002025325811027906
   PubMed Web of Science ®Google Scholar
• KressHGOronskaAKaczmarekZKaasaSColbergTNolteTEfficacy and tolerability of intranasal fentanyl spray 50 to 200 μg for breakthrough pain in patients with cancer: A Phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment periodClin Ther2009311177119119695386
   PubMed Web of Science ®Google Scholar
• MercadanteSRadbruchLDaviesAA comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: An open-label, randomised, crossover trialCurr Med Res Opin2009252805281519792837
   PubMed Web of Science ®Google Scholar
• StamWVissersDLenreMAn economic evaluation of fast-acting opioids for the treatment of breakthrough pain in cancer patients in SwedenEur J Pain200913Suppl 1S241
   Google Scholar
• BurkeyABallantyneJThe role of rapid-onset fentanyl in clinical practiceEur J Palliat Care2010178890
   Google Scholar
• CarrDBGoudaslCDenmanWTSafety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: A randomized, double-blind, placebo-controlled, crossover studyPain2004108172715109503
   PubMed Web of Science ®Google Scholar